T he CD4
+ CD8 + double-positive (DP) stage of T cell development encompasses critical developmental checkpoints, including rearrangement of the T cell antigen receptor (TCR) alpha (Tcra) locus, assembly of the α β T cell receptor (α β TCR), and passage through thymic selection 1 . DP thymocytes arise from the proliferative double-negative (DN) 4 stage, which is controlled by cooperative pre-TCR and Notch signals 2 . Coordination among transcriptional regulators has been established for early stages of T cell development, in which Notch signals activate transcription of TCF-1 (encoded by Tcf7) 3, 4 and GATA-3 (refs 5, 6 ), whereas Pu.1 regulates the binding-site choice of Runx1 and consequently the initiation of the T cell program [7] [8] [9] . Together, Notch, TCF-1, GATA-3, and Runx1 activate Bcl11b and seal the T cell fate 7, 10 . T cell commitment in DN2 cells coincides with the upregulation of HEB (encoded by Tcf12), HEBAlt (HEB isoform), Runx1, Gfi1, and Ets1, which control subsequent T cell developmental stages 7, [11] [12] [13] . Despite intense investigation, the orchestration of factors that regulate entry into and differentiation through the DP stages remains poorly understood.
Regulatory proteins implicated in the DP stages include TCF-1 (refs 14, 15 ) and HEB 16 . TCF-1, a member of the HMG-domaincontaining Tcf/Lef family of transcriptional regulators, participates in complex transcriptional and epigenetic processes throughout T cell development. It interacts with β -catenin, thereby activating Wnt-target genes, and with Groucho, thereby silencing genes [17] [18] [19] . Although TCF-1 has intrinsic histone deacetylase activity 20 , it also promotes chromatin accessibility and displaces nucleosomes at its binding sites 21 . The specific transcriptional and epigenetic functions of TCF-1 at the DP stage and its potential cooperation with other regulators remain unclear. HEB is a member of the E-protein family of transcription regulators, which are essential for the development of both B and T cells 22 . Through its helix-loop-helix domain, HEB can form homodimers as well as heterodimers with other E proteins, and consequently mediate positive and negative regulation of gene expression. Although HEB binds the acetyltransferase p300 (ref. 23 ), its genome-wide chromatin-remodeling functions remain unclear.
In germline TCF-1-deficient thymocytes, the transition to the DP stage is impaired 14, 15 . TCF-1 also controls the lifespan of DP thymocytes by upregulating the antiapoptotic protein Bcl-XL [24] [25] [26] . These shorter-lived DP thymocytes do not undergo distal Tcra gene rearrangements and therefore generate fewer natural killer T cells, which depend on these rearrangements 26 . Like TCF-1, HEB regulates the transition to the DP stage as well as the survival of DP thymocytes, and its deletion limits distal Tcra rearrangements and development of natural killer T cells 27 . After the DP stage, TCF-1 promotes the CD4 + versus CD8 + T cell fate 28 . HEB is also required for CD4 + lineage commitment 29 . Thus, TCF-1 and HEB are fundamental in guiding thymocytes into and beyond the DP stages of development; however, whether they collaborate directly remains unclear.
Here, we found that most HEB-bound DNA sites genome wide were also bound by TCF-1. Cobinding of TCF-1 and HEB promoted chromatin accessibility, whereas TCF-1 predominantly limited nucleosome occupancy. TCF-1/HEB cobinding to their conserved motifs at the enhancers of genes involved in α β T cell development correlated with transcriptional upregulation. In contrast, TCF-1 and HEB bound to sites that lacked their conserved motifs in the promoters of cell-cycle-associated genes, and ablation of either TCF-1 or HEB increased DP-thymocyte proliferation. Importantly, TCF-1 limited Notch signaling, which targets HEB for proteasomal degradation. Therefore, TCF-1 both enhances HEB protein stability and 
CD8
+ thymocytes elicits similar developmental outcomes including increased proliferation, decreased survival, and fewer late Tcra rearrangements. Here, we provide a mechanistic explanation for these similarities by showing that TCF-1 and HEB share ~7,000 DNA-binding sites genome wide and promote chromatin accessibility. The binding of both TCF-1 and HEB was required at these shared sites for epigenetic and transcriptional gene regulation. Binding of TCF-1 and HEB to their conserved motifs in the enhancer regions of genes associated with T cell differentiation promoted their expression. Binding to sites lacking conserved motifs in the promoter regions of cell-cycle-associated genes limited proliferation. TCF-1 displaced nucleosomes, allowing for chromatin accessibility. Importantly, TCF-1 inhibited Notch signaling and consequently protected HEB from Notchmediated proteasomal degradation. Thus, TCF-1 shifts nucleosomes and safeguards HEB, thereby enabling their cooperation in establishing the epigenetic and transcription profiles of CD4 + CD8 + thymocytes.
functionally cooperates with HEB in defining the epigenetic and transcriptional status of DP thymocytes.
results

TCF-1 binding marks actively transcribed genes.
We previously established, through chromatin immunoprecipitation and deep sequencing (ChIP-seq) 30 ,31 that in wild-type (WT) thymocytes, TCF-1 binds more than 16,000 sites genome wide. To identify regions of accessible chromatin in WT DP thymocytes, we performed the assay for transposase-accessible chromatin and deep sequencing (ATAC-seq). Alignment of the ATAC-seq results to our TCF-1 ChIP-seq data established that the chromatin surrounding the TCF-1 peaks in DP thymocytes was highly accessible (Fig. 1a) . We also mapped the landscape of histone marks indicating poised/active (mono-and dimethylated histone H3 Lys4 (H3K4me1 and H3K4me2, respectively)), active (trimethylated H3 Lys 4 (H3K4me3) and acetylated H3 (H3ac and H3K27ac)), and repressed (trimethylated H3 Lys27 (H3K27me3)) chromatin proximal to TCF-1 sites. Of the TCF-1-bound sites, 43% were at active promoters enriched in H3K4me2/me3, H3ac, and H3K27ac histone marks as well as RNA polymerase (Pol) II, indicating transcriptional activity. Additionally, 24% of the TCF-1 bound sites were active enhancers, enriched in H3K4me1/ me2, H3K27ac, and RNA Pol II, and 33% were poised enhancers marked by H3K4me1 but displaying low enrichment in H3K4me2 and H3K27ac, and lacking RNA Pol II (Fig. 1a-c) . In contrast, TCF-1 binding rarely overlapped with the repressive H3K27me3 mark. Thus, TCF-1 occupies gene-regulatory regions enriched in marks of poised or active chromatin, thereby indicating that it directly regulates gene expression.
TCF-1 binding at open chromatin sites, enriched in RNA Pol II, suggested that its gene targets are actively transcribed. RNAseq analysis of sorted WT DP thymocytes showed that the average expression of TCF-1-bound genes was higher than that of all expressed genes (Fig. 1d) . In particular, genes bound by TCF-1 at promoters or at both promoter and enhancer regions showed significantly higher expression than genes bound only at active or poised enhancer regions. Thus, TCF-1 binds accessible regulatory regions of actively transcribed genes. Pathway enrichment analysis (http://www.metascape.org/) revealed that TCF-1 binding to promoters alone versus enhancers marks genes involved in distinct processes (Fig. 1e) . Genes bound by TCF-1 only at promoter regions were involved in cell-cycle regulation. In contrast, TCF-1 binding at enhancers or both enhancer and promoter regions marked genes involved in T cell developmental processes. These findings suggest that TCF-1 differentially regulates these distinct processes through specific chromatin binding patterns, potentially in coordination with other factors.
TCF-1 shares binding sites with other lymphoid factors.
To identify additional factors that might cooperate with TCF-1, we first analyzed TCF-1-binding sites for common motifs. TCF-1-bound sites were highly enriched in the conserved Tcf/Lef motif (P = 1 × 10 -1784
). Additionally, motifs for Ikaros/Ets, Runx and basic helix-loop-helix domain-containing proteins were also significantly enriched at TCF-1-bound sites (Fig. 2a) . These factors are essential during the transitions to the DP and single-positive stages of thymocyte development. Ikaros regulates differentiation from the CD4 +
CD8
lo postselected DP to the single-positive subsets, and its deletion predisposes mice to Notch-dependent thymic lymphomas 32, 33 . Runx1 is involved in the progression from the DN to DP and single-positive stages and, with Runx3, is essential for CD8 + lineage commitment 34 . Likewise, the basic helix-loop-helix domaincontaining E2A and HEB regulate progression into, and exit from, the DP stage. Interestingly, HEB deficiency impairs thymic development in a manner akin to TCF-1 deficiency 16, 27 .
The involvement of these regulators in the DP stages of thymocyte development, and the enrichment of their motifs at TCF-1-bound sites, prompted us to examine whether their binding might overlap with that of TCF-1. We performed ChIP-seq for HEB and analyzed published ChIP-seq data for Ikaros 35 , and Runx1 (ref. 36 ) in WT thymocytes. We also performed ChIP-seq for Lef-1, which recognizes the same motif as TCF-1 and is thought to have redundant functions 37, 38 . Even though Lef-1 occupied significantly fewer sites than TCF-1 (4,476/16,377), 79% of these sites (3,536) overlapped with TCF-1 (Fig. 2b) . TCF-1-binding sites also overlapped with 53% of Ikaros-binding sites (2,018) and 47% of Runx1-binding sites (4, 970) . HEB shared the largest number of overlapping sites with TCF-1 (6,767), representing 55% of all HEB peaks. The peak summits of Ikaros, Runx1, and HEB in common sites with TCF-1 completely overlapped with TCF-1 peak summits, thus indicating that binding of these factors was centered on the same sequences ( Fig. 2c-e) .
We compared chromatin accessibility at sites bound by TCF-1 alone (6,883) with sites where TCF-1 overlapped with one other factor (5,482 sites; 63% with HEB, 28% with Runx1, and 9% with Ikaros), two factors (3,280 sites; 76% with HEB/Runx1 and 24% with HEB/Ikaros), or sites in which all four factors overlapped (732 sites). TCF-1 enrichment (peak score) and chromatin accessibility (ATAC-seq) progressively increased at sites where TCF-1 overlapped with additional factors, suggesting cooperativity (Fig. 2f) . HEB was the preferential binding partner of TCF-1, sharing an extensive number of sites with TCF-1 as well as all multifactor TCF-1 sites. These findings led us to further investigate the functions of TCF-1 and HEB in DP thymocytes.
TCF-1 and HEB guide similar developmental processes.
To understand the potential cooperative functions of TCF-1 and HEB, we compared thymocyte development after DP-specific deletion of either Tcf7 or Tcf12. Conditional loss of TCF-1 or HEB, respectively, was accomplished with a Cd4-Cre transgene. Whereas Cd4-CreTcf12 fl/fl mice (hereafter referred to as HEB deficient) exhibited sufficiently decreased HEB protein abundance in preselected DP thymocytes, the effective decrease in TCF-1 protein in the preselected DP thymocytes required crossing Cd4-Cre to Tcf7 fl/-mice (hereafter referred to as TCF-1 deficient), as previously described 28 . Multiple studies have established that heterozygous TCF-1 deletion does not affect DP-thymocyte development 14, 15, 39 . TCF-1 or HEB deficiency mildly decreased thymic cellularity (Fig. 3a) . In accordance with published observations 26, 27 , both TCF-1-and HEB-deficient DP thymocytes had greater apoptosis (annexin V + ), than did thymocytes from littermate controls (Cd4-Cre) (Fig. 3b) . Additionally, qPCR showed that Tcra gene rearrangements were strongly biased for proximal and against distal Jα gene segments, in both TCF-1-and HEB-deficient DP thymocytes, probably because of the shorter lifespan of these cells (Fig. 3c) . We further found that TCF-1-or HEB-deficient DP thymocytes were significantly more proliferative than thymocytes from littermate controls (Fig. 3d ). Higher proliferation rates did not result from increased DP-blast thymocytes in Cd4-CreTcf7 fl/-and Cd4-CreTcf12 fl/fl thymi compared with WT thymi, because the fraction of CD71 + FSC hi blast DP cells did not significantly change ( Supplementary Fig. 1 ). Thus, in addition to having overlapping genome-wide binding, TCF-1 and HEB regulate the same critical properties of DP thymocytes, suggesting that TCF-1 and HEB cooperatively regulate the DP stage of thymocyte development.
TCF-1/HEB shared sites mark genes involved in T cell development. Like TCF-1, HEB bound to accessible chromatin sites. The mean expression of HEB-bound genes was higher than that of all genes expressed in DP thymocytes. Genes bound by HEB at the promoters or both promoter and enhancer sites had the highest expression ( Supplementary Fig. 2 ). To assess the potential cooperation between TCF-1 and HEB in DP thymocytes, we analyzed their overlapping binding sites. These sites were distributed to promoters as well as poised and active enhancers ( Fig. 4a-d ). The average expression of TCF-1/HEB cobound genes was significantly higher than that of all DP-thymocyte genes or genes uniquely bound by either TCF-1 or HEB (Fig. 4e) . In particular, genes cobound by TCF-1 and HEB at both promoter and enhancer sequences showed the highest expression, followed by genes with binding at the promoter only.
Shared TCF-1 and HEB binding at promoters versus enhancers differed in several aspects. First, TCF-1 and HEB enrichment was highest at active enhancers (Fig. 4c) . Second, TCF-1/HEB cobinding at promoters versus enhancers marked distinct groups of genes. Binding only to promoters marked genes involved in general cellular processes, such as cell division and the DNA-damage response ( Fig. 4f and Supplementary Fig. 3 ). However, binding to enhancers or enhancers as well as promoters marked genes involved in T cell-specific processes, such as T cell activation and TCR signaling. This binding pattern resembled that observed for all TCF-1-bound sites ( Fig. 3b-d) . We further identified regions with extensive TCF-1 and HEB binding by using a rank-order super-cluster algorithm that stitches together adjacent transcription-factor peaks within 12.5-kb regions 40 . Of the 271 TCF-1 and 213 HEB super-clusters identified ( Supplementary Fig. 4 ), 126 overlapped, and most were in enhancers, whereas only 11 were located in promoters. Overlapping super-clusters occurred mostly at the enhancers of genes involved in TCR signaling, recombination, and apoptosis, highlighting DP-thymocyte processes affected by ablation of TCF-1 or HEB. Thus, TCF-1/HEB cobinding to gene promoters versus enhancers identifies distinct processes. Independently deleting either protein functionally impairs these processes in DP thymocytes, suggesting that TCF-1 and HEB cooperatively regulate the transcriptional and/ or epigenetic state of the associated genes.
TCF-1 and HEB promote chromatin accessibility at cobound sites. To determine the importance of the extensive binding overlap between TCF-1 and HEB, we assessed the binding of HEB in TCF-1-deficient DP thymocytes and of TCF-1 in HEB-deficient DP thymocytes by ChIP-seq (Fig. 5) . Only 2,813 high-confidence (P = 10 × 10 -5 ) HEB sites were identified in TCF-1-deficient thymocytes, compared with 12,233 in WT thymocytes, reflecting a 73% decrease ( Supplementary Fig. 5a,b) . Of these sites, 84% were also bound by HEB in WT thymocytes, and 489 were new. Of the HEB sites in TCF-1-deficient thymocytes (Fig. 5a,b ), 68% were cobound by TCF-1 and HEB in WT thymocytes, indicating that HEB binding at these sites does not require the presence of TCF-1. In addition, 5 kb) . b, Comparative enrichment histograms of permissive histone modifications (H3ac, H3K4me1, H3K4me2, H3K4me3, and H3K27ac) and chromatin accessibility (ATAC-seq) at overlapping TCF-1-and HEB-binding sites (± 1.5 kb) in clusters identified in a. c, ChIP-seq enrichment of TCF-1 (top) and HEB (bottom) at regions of overlapping TCF-1 and HEB binding identified in a (± 1.5 kb). d, Genomic distribution of overlapping TCF-1-and HEB-binding sites in WT thymocytes. e, Average expression in DP thymocytes of genes in the indicated groups. E, enhancer; P, promoter. Numbers are mean log 2 FPKM (****P ≤ 0.0001, KruskalWallis test; error bars, s.d.). (All genes, n = 23,360; unbound genes, n = 13,710; TCF-1 alone, n = 2,630 genes; HEB alone, n = 1,174 genes; TCF-1 and HEB, n = 5,846 genes; promoter, n = 3,098 genes; active enhancer, n = 1,160 genes; poised enhancer, n = 1,067 genes; promoter + enhancer, n = 521 genes). f, Functional pathways enriched in genes bound by both TCF-1 and HEB in promoters or promoters and enhancers. (Active enhancer, n = 1,160 genes; poised enhancer, n = 1,067 genes; promoter, n = 3,098 genes; promoter + enhancer, n = 521 genes). Pathways and statistical enrichment were determined by Metascape. the average enrichment of HEB at the remaining binding sites was also markedly lower in TCF-1-deficient than WT thymocytes ( Fig. 5c and Supplementary Fig. 5c ). HEB enrichment was most decreased at poised enhancers, followed by active enhancers and then promoters (Fig. 5d) . The number of TCF-1-binding sites was only moderately lower in HEB-deficient than HEB-containing thymocytes (from 16,377 to 14,409). Of these remaining sites, 10,007 (70%) overlapped with TCF-1-binding sites in WT thymocytes, whereas 4,402 were new ( Supplementary Fig. 5d,e) . Although most TCF-1-bound sites were maintained in the absence of HEB, TCF-1 enrichment in the remaining sites was decreased (Fig. 5c and Supplementary Fig. 5f ). Similarly to HEB binding, TCF-1 binding was also primarily decreased at active and poised enhancers (Fig. 5d) . Thus, TCF-1 and HEB each affect the enrichment of the other on DNA; however, the severe decrease in the number of HEB-binding sites in TCF-1-deficient cells is likely to be an indirect effect of the absence of TCF-1.
TCF-1 has multiple epigenetic and chromatin conformation functions 18, 21 ; however, a role for HEB in shaping the chromatin has not yet been established 23 . Therefore, we examined the effect of TCF-1 and HEB on the chromatin landscape. We compared chromatin accessibility in WT and TCF-1-or HEB-deficient DP thymocytes by using ATAC-seq ( Supplementary Fig. 6 ). We found 51,452 (P = 1.0 × 10 ) motifs (Supplementary Fig. 6a ). TCF-1 (P = 1 × 10 -82
) and HEB (P = 1 × 10 -112 ) were also among the five most enriched motifs in the 7,241 sites that were accessible in WT but lost accessibility after ablation of TCF-1 or HEB (Supplementary Fig. 6e ). However, accessible regions in TCF-1-deficient and HEB-deficient DP thymocytes were relatively depleted in TCF-1 and HEB conserved motifs, as compared with WT ( Supplementary Fig. 6b,c) . Importantly, regions that gained accessibility in TCF-1-or HEB-deficient DP thymocytes were not enriched in TCF-1 or HEB motifs ( Supplementary Fig.  6f,g ). Additionally, novel HEB-and TCF-1-binding sites detected in TCF-1-or HEB-deficient thymocytes, respectively, were not at these newly accessible regions. These findings demonstrate that TCF-1 and HEB promote accessibility at sites containing TCF-1 and HEB motifs. Moreover, they indicate that E2A, the partner of HEB, does not significantly compensate for the loss of accessibility at HEBmotif-containing sites.
Genomic sites bound by TCF-1 or HEB in WT thymocytes were less accessible in HEB-or TCF-1-deficient DP thymocytes, respectively, and binding enrichment was greatly decreased ( Supplementary Fig. 5c,f) . Importantly, TCF-1/HEB-cobound sites were also less accessible in the absence of either TCF-1 or HEB (Fig. 5a,c) . The degree of accessibility loss was more pronounced at cobound enhancers, particularly active enhancers (Fig. 5d) , where the TCF-1 and HEB binding enrichment was highest (Fig. 4c) . The novel finding that HEB deletion decreased chromatin accessibility is consistent with its known interaction with p300 (ref. 23 ) and establishes that HEB has genome-wide epigenetic functions.
We next examined whether decreased chromatin accessibility in the absence of TCF-1 or HEB might also reflect changes in the nucleosome landscape. Nucleosome tracks were generated from paired-end ATAC-seq of WT, TCF-1-deficient, and HEB-deficient DP thymocytes. The nucleosome occupancy at TCF-1/HEBcobound sites was calculated with the UCSC tool bigWigAverageOverBed. This tool assigns a probability score for the presence of a nucleosome at each site. Positive values indicate high probability, and negative values indicate low probability. In agreement with the decreased chromatin accessibility, the probability that nucleosomes occupied TCF-1/HEB-cobound sites was higher in TCF-1-and HEBdeficient DP thymocytes than WT thymocytes (Fig. 5e) . However, although the probability of nucleosome occupancy was substantially higher in TCF-1-deficient DP thymocytes (P < 2.2 × 10 -16 ), the increase in HEB-deficient DP thymocytes was only marginally significant (P = 0.0012; Fig. 5e ). De novo nucleosome occupancy at TCF-1/HEB-cobound sites in TCF-1-deficient thymocytes is also shown for the Tgfbrap1 and Calm1 genes. This finding is in line with a recent report demonstrating that TCF-1 can shift nucleosomes 21 .
The dominant role of TCF-1 in controlling nucleosome occupancy was further confirmed for sites uniquely bound by TCF-1 or by HEB in WT thymocytes (Fig. 5f ). The nucleosome occupancy at sites bound by TCF-1 alone was substantially higher in TCF-1-deficient DP thymocytes (P < 2.2 × 10 -16 ). However, at sites bound by HEB alone, this increase in HEB-deficient thymocytes was only marginally significant (P = 0.00025). Overall, our findings show that TCF-1 and HEB coordinately regulate chromatin accessibility, and TCF-1 has a dominant role in controlling the presence of nucleosomes at cobound sites in DP thymocytes.
TCF-1/HEB cobinding to their motifs promotes gene expression.
Several DP-thymocyte processes depend on the presence of TCF-1 and HEB. Therefore, we investigated whether the TCF-1/HEB cobinding in DP thymocytes might reflect regulation of overlapping transcriptional programs. We identified significant (P = 0.05) gene expression changes in both TCF-1-deficient (n = 1,269) and HEBdeficient (n = 838) DP thymocytes compared with WT thymocytes. Spearman's rank-correlation comparison of the two sets established that transcriptional changes associated with TCF-1 deficiency mirrored the transcriptional changes associated with HEB deficiency (Spearman correlation = 0.36, P = 1.99 × 10 -61
; Fig. 6a ). This finding establishes that through their extensive cobinding and epigenetic functions, TCF-1 and HEB cooperatively regulate the transcriptional profile of DP thymocytes.
Ablation of either TCF-1 or HEB limited binding of the other factor to DNA and decreased chromatin accessibility, particularly at active enhancers. To determine whether TCF-1/HEB cobinding at distinct regulatory regions differentially modulates gene transcription, we compared expression changes in WT versus TCF-1-or HEB-deficient DP thymocytes, according to the region bound. TCF-1/HEB-cobound genes in WT thymocytes were divided into clusters exhibiting promoter-only binding, enhancer-only binding (poised or active), or both promoter and enhancer binding (poised or active). Expression changes in WT versus TCF-1-deficient and WT versus HEB-deficient DP thymocytes within these clusters were subjected to cumulative distribution function (CDF) analysis and compared to expression changes of all genes (Fig. 6b) . TCF-1/ HEB cobinding at promoter-only or poised enhancer-only clusters was equally likely to confer up-or downregulation of the associated gene. Notably, TCF-1/HEB cobinding at active enhancer sites or both enhancer and promoter sites was significantly more likely to promote upregulation of the associated gene. Thus, DNA binding and epigenetic and transcriptional analyses cumulatively established that TCF-1/HEB cobinding to active enhancers or enhancers and promoters increases chromatin accessibility and promotes expression of the associated genes.
We found that TCF-1 and HEB promote accessibility at sites containing TCF-1 and HEB motifs (Supplementary Fig. 6 ). However, not all TCF-1/HEB-cobound sites contain TCF-1 and HEB motifs. Therefore we tested whether the transcription of gene targets was dependent on TCF-1 and HEB binding to their motifs. Cobound regions were subdivided into two clusters on the basis of whether they contained TCF-1 and HEB motifs. The expression changes of genes associated with each cluster in WT versus TCF-1-deficient and WT versus HEB-deficient thymocytes were compared with the expression changes of all genes in CDF analyses (Fig. 6c) . Genes associated with motifs containing TCF-1 and HEB peaks were significantly more likely to be downregulated under ablation of either fl/fl versus WT (right) for genes bound by TCF-1 and HEB in WT thymocytes. Black curves indicate expression changes of all genes expressed in DP thymocytes, and red curves indicate expression changes of genes bound by TCF-1 and HEB in the indicated genomic regions. log 2 expression changes are shown; P values indicate the significance of the difference between red and black curves (two-tailed Mann-Whitney U test). (Promoter, 2,577 genes; poised enhancer, 661 genes; active enhancer, 624 genes; promoter + poised enhancer, 154 genes; promoter + active enhancer, 283 genes; all black curves, 23,360 genes. c, CDF plot of expression changes as in b of all genes bound by TCF-1 and HEB in WT (top) thymocytes, genes bound by TCF-1 and HEB at sites that contain their conserved motifs (middle), and genes bound by TCF-1 and HEB at sites that do not contain their conserved motifs (bottom). Pathways enriched within genes containing or lacking motifs are shown next to the relevant CDF plot. P values were determined with a two-tailed Mann-Whitney U test. (All cobound genes, n = 4,299; genes with TCF-1 and HEB motifs, n = 1,790; genes without TCF-1 and HEB motifs, n = 2,509. d, Comparative enrichment histogram plots of the indicated histone marks and changes in chromatin accessibility centered on TCF-1 and HEB binding sites (± 1.5 kb) at the indicated sites. e, Number of overlapping downregulated genes (P ≤ 0.05, Cuffdiff) (top) in TCF-1-or HEBdeficient DP thymocytes (RNA-seq) within 20 kb of TCF-1/HEB-cobound sites identified with BETA. Middle, enriched motifs in the TCF-1/HEB-cobound sites (1,469) within 20 kb of downregulated genes. Bottom, Metascape pathways enriched within downregulated genes with TCF-1 and HEB motifs identified by BETA (349 genes). f, Number of overlapping upregulated genes (P ≤ 0.05, Cuffdiff) (top) identified by BETA (693) within 20 kb of TCF-1/ HEB-cobound sites (1,005 sites) . Bottom, Metascape pathways enriched in upregulated genes.
TCF-1 or HEB and were enriched in T cell-development pathways (Supplementary Table 1 ). However, genes associated with TCF-1 and HEB peaks lacking TCF-1 and HEB motifs did not show consistent changes and were enriched in cell-cycle and chromatin processes (Supplementary Table 2 ). Our two independent CDF analyses showed that TCF-1/HEB cobinding to active enhancers or to their conserved motifs promoted gene expression. To link these findings, we assessed the genomic location of cobound regions containing TCF-1 and HEB motifs to regions lacking such motifs, on the basis of their chromatin landscape. Sites containing TCF-1 and HEB motifs were highly enriched in the enhancer H3K4me1 mark, whereas sites lacking these motifs were more enriched in the promoter mark H3K4me3 (Fig. 6d) . Thus, TCF-1/HEB cobinding to sites that contain their conserved motif predominantly at enhancers promotes expression of the corresponding genes.
To independently establish that TCF-1/HEB cobinding to their conserved motifs correlates with gene upregulation, we performed binding and expression target analysis (BETA) 41 . Using BETA, we identified in WT shared TCF-1 and HEB peaks located within 20 kb of the transcription start sites of genes that changed in expression in the absence of TCF-1 or HEB compared with WT. The 1,053 genes commonly downregulated in the absence of TCF-1 or HEB represented 1,469 TCF-1/HEB-cobound sites (Fig. 6e) . Additionally, the 693 commonly upregulated genes represented 1,005 TCF-1/HEBcobound sites (Fig. 6f) . In agreement with the CDF analyses, motif enrichment at these shared sites differentiated downregulated from ) motifs (Fig. 6e) . Analysis of motif-containing sites identified 349 genes involved in T cell-differentiation processes (Fig. 6e) . In contrast, the 693 upregulated genes that lacked TCF-1-and HEB-motif enrichment were involved in proliferation and DNA-repair processes. Overall, our analyses indicate that cobinding of TCF-1 and HEB to their conserved motifs, predominantly at enhancers, promotes the expression of genes essential for DP thymocyte development.
TCF-1 regulates HEB stability by limiting Notch signaling. We showed that TCF-1 and HEB coordinately regulate the chromatin landscape and transcription profiles of DP thymocytes. However, it was unclear why HEB binding was severely decreased in TCF-1-deficient thymocytes, whereas TCF-1 binding was less affected in HEB-deficient thymocytes. Tcf12 mRNA abundance was similar between WT and TCF-1-deficient cells (Fig. 7a) . However, immunoblot analyses showed that HEB protein expression was potently decreased and comparable to that observed in HEB-deficient DP thymocytes (Fig. 7a) . Notch signaling was previously reported to induce ubiquitination of E2A, thus resulting in its degradation [42] [43] [44] . We investigated whether a similar process might have decreased HEB protein abundance in TCF-1-deficient DP thymocytes. Our RNA-seq data showed that the Notch and ubiquitination pathways were transcriptionally upregulated in TCF-1-deficient DP thymocytes (Fig. 7b) . Gene-set enrichment analysis showed that the Notch signaling cascade (Hallmark_Notch_signaling) was selectively upregulated in TCF-1-deficient but not HEB-deficient DP thymocytes compared with WT thymocytes (Fig. 7c,d ). In particular, TCF-1 bound without HEB to 103 regions of Notch-pathway genes ( Supplementary Fig. 7 ). Two-thirds of these regions were at enhancers, and histone-mark enrichment as well as accessibility patterns most closely corresponded to poised enhancers. However, TCF-1 ablation did not decrease accessibility at these sites as severely as at TCF-1/HEB-cobound poised/active enhancers, thus potentially allowing for transcription of the corresponding Notchpathway genes.
To determine whether the upregulation of the Notch and ubiquitin ligase pathways caused the decreased HEB protein abundance in TCF-1-deficient thymocytes, we sorted WT and TCF-1-deficient DP thymocytes and performed immunoblot analysis to assess HEB protein after treatment with the proteasome inhibitor MG132 (5 μ M) or the Notch inhibitor DAPT (10 μ M). Both proteasome and Notch inhibition restored HEB protein abundance in TCF-1-deficient DP thymocytes (Fig. 7e) . These findings indicate that ablation of TCF-1 increases Notch signaling and consequently promotes proteasomal degradation of HEB. Therefore, by inhibiting Notch signaling, TCF-1 stabilizes HEB, thus allowing for their coordinated functions at the DP stage of thymocyte development.
Discussion
Thymocytes transitioning to the DP stage cease proliferating, rearrange the Tcra gene, and assemble the α β TCR 45 . Coordinating these events requires precise transcriptional and epigenetic reprograming of developing thymocytes. Here, we identified TCF-1 and HEB as cooperating partners regulating chromatin accessibility and gene expression in DP thymocytes, We show that TCF-1 and HEB cooperatively halt the proliferation of early DP thymocytes and promote survival and T cell development. This regulation involves extensive overlap of TCF-1 and HEB DNA binding. TCF-1 and HEB promote chromatin accessibility, whereas predominantly TCF-1 minimizes nucleosome occupancy. Importantly, TCF-1 stabilizes HEB protein by limiting its Notch-mediated proteasomal degradation.
Developmental programs depend on the coordination of regulators and epigenetic organizers 3,4,7,8,10,46,47 . Here, we found that TCF-1, which reaches its highest expression in DP thymocytes (https://www.immgen.org/), binds the promoters and enhancers of highly expressed genes, where it shares binding sites with other factors, including Runx1, Ikaros, and HEB. The essential functions of TCF-1 (refs 4, 14, 15, 39 ), HEB 16, 29, 48, 49 , Runx1 (ref. 34 ), and Ikaros 50 in thymocyte development, and their differential abilities to modulate chromatin landscapes, suggest that they regulate this developmental process through a complex interplay. In early thymic development, TCF-1 has been shown to coordinate with Notch1, GATA-3, and Runx1, in a proccess that culminates in Bcl11b activation and T cell commitment 7 . Furthermore, a recent report has demonstrated that TCF-1 promotes de novo chromatin opening 21 . Our study focused on the cooperation between TCF-1 and HEB at the DP stage, in which the two factors share an extensive number of binding sites as well as common developmental functions. Particularly, ablation of either TCF-1 or HEB decreases DP-thymocyte survival, affects development of natural killer T cells 26, 27 , and increases DP-thymocyte proliferation. TCF-1 and HEB share binding to sites that contain their conserved motifs predominantly at the enhancers of genes involved in T cell development and positively co-regulate their expression. In contrast, TCF-1 and HEB share binding sites lacking their conserved motifs and negatively coregulate the expression of genes involved in proliferation.
Although HEB binds the histone acetyltransferase p300 (ref. 23 ), it has not been directly shown to modulate the chromatin landscape. Here, we demonstrate that HEB promotes chromatin accessibility genome wide in DP thymocytes. This epigenetic function of HEB is distinct from the epigenetic functions of TCF-1, because HEB-deficient cells have diminished chromatin accessibility despite normal TCF-1 protein abundance. Additionally, the accessibilitypromoting functions of HEB and TCF-1 are not complementary. Chromatin closing in HEB-deficient cells, which maintain TCF-1 protein, is comparable to that in TCF-1-deficient cells, which also lose HEB protein expression. Moreover, E2A, the interacting partner of HEB 22, 29 , does not compensate for the epigenetic functions of HEB, because HEB-deficient DP thymocytes specifically lose accessibility in regions containing the common HEB/E2A-binding motif. In agreement with promoting chromatin accessibility, predominantly TCF-1, and marginally HEB, limit nucleosome occupancy in their cobound sites. This conclusion is supported by the finding that sites uniquely bound by TCF-1 have increased nucleosome presence, whereas sites uniquely bound by HEB show only a marginal increase after loss of TCF-1 or HEB, respectively. Altogether, our findings suggest that TCF-1 and HEB coordinately shape the chromatin landscape of DP thymocytes; both are needed for promoting chromatin accessibility, but they do not have complementary effects. In contrast, TCF-1 has a dominant role over HEB in regulating the nucleosomal landscape.
We discovered that, beyond TCF-1 and HEB binding the same genomic locations and mediating epigenetic and transcriptional regulation, TCF-1 regulates HEB protein stability. TCF-1 accomplishes this function through a higher-level coordination whereby TCF-1 controls the levels of Notch signaling, and Notch signaling in turn controls HEB stability. The targeting of HEB by Notch signaling parallels the previously established Notch-mediated targeting of E2A, a possible heterodimerization partner of HEB, for ubiquitination and proteasomal degradation [42] [43] [44] . Notch signaling is gradually downregulated as cells progress to the DP stage, whereas the activity of TCF-1 and HEB is essential for the transition into the DP stage. Our data suggest that TCF-1 mediates the downregulation of Notch, thereby facilitating stabilization of the HEB protein, which in turn enables their coordinated actions in promoting DP-thymocyte development.
Our studies offer a novel understanding of the complex regulatory network that controls DP-thymocyte development. We demonstrate that TCF-1/HEB cobinding to promoters versus enhancers, identifies genes involved in distinct processes and differentially affects their transcription and epigenetic status. TCF-1 has an epistatic role in regulating common TCF-1 and HEB functions through its ability to stabilize the HEB protein by modulating Notch signaling. TCF-1/HEB-cobound sites are enriched for different transcription-factor motifs. Cobound genes that are downregulated by the presence of TCF-1 and HEB lack the conserved TCF-1 and HEB motifs. This result suggests that TCF-1 and HEB potentially organize and/or participate in complex networks of regulators that change dynamically as cells enter and progress within the DP stage. Future studies are expected to decipher the complex orchestration between TCF-1 and Notch signaling in the regulation of HEB. Additionally, future studies will address the coordination of TCF-1 and HEB with other lymphoid factors, such as Runx1 and Ikaros, and their combined effects on chromatin organization, gene expression, and DP-thymocyte development.
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binding sites, and reported as confidence scores. Negative values indicated the absence of nucleosomes, whereas positive values represented an increased likelihood of the presence of a nucleosome at each region.
Density plots (Spearman correlation).
Density plots were created with the stat_bin2d function in the ggplot2 package in R, with 30 bins in each dimension. For visualization purposes, the axis ranges of some density plots were limited to highlight the high-probability regions of the plot.
Spearman correlation coefficients and P values were computed in R with the cor and cor.test functions.
Statistical analysis.
Results from biologically distinct experiments were combined and analyzed with the indicated statistical tests in Prism 7 (GraphPad). The statistical significance of RNA-seq data was determined with Cuffdiff. ChIP-seq (factor enrichment) and ATAC-seq (chromatin accessibility) P-value cutoffs were determined with MACS2. Gene pathway enrichment P values were determined with Metascape. Nucleosome-occupancy statistical tests were calculated in R. Data are presented as mean ± s.d. unless stated otherwise.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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Data collection
No software was used for data collection.
Data analysis HOMER, MACS2, bigWigAverageOverBed, wigToBigWig, FlowJo, Prism, R, Cuffdif, NGSPLOT, BETA, Metascape, Cluster, and Integrated Genome Browser were used for data analysis and visualization.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability RNA-seq, ChIP-seq and ATAC-seq data sets have been deposited in the GEO database with accession code SRP142342.
